Nursing Best Practice Recommendations for Intravesical Instillation in Bladder Cancer: Adaptation to the Portuguese Oncological Care
DOI:
https://doi.org/10.31877/on.2025.51.03Keywords:
Administration, Intravesical, Bacillus Calmette–Guérin, Evidence-Based Practice, Mitomycin, Oncology NursingAbstract
The study aimed to translate and adapt best practice recommendations for intravesical instillation of antineoplastic therapy by the European Association of Urology Nurses to the Portuguese oncological context. The work followed the ADAPTE methodology, involving three phases (preparation, adaptation, and finalisation), including external review using the Delphi method.
The translation and adaptation resulted in terminological standardisation and the exclusion of elements misaligned with the national context. Recommendations that did not reach consensus within the working group (n=16) were externally evaluated by expert nurses in intravesical antineoplastic therapy from various oncological contexts identified by intentional and snowball sampling (N=19 Round I, N=16 Round II). Four initial recommendations did not reach consensus; two were eliminated, and the remaining were evaluated in a second round.
This study successfully adapted the recommendations to the Portuguese context, promoting evidence-based practices. Validation by an expert panel confirms their relevance and applicability, strengthening oncological care in Portugal.
The translation and adaptation resulted in terminological standardisation and the exclusion of elements misaligned with the national context. Recommendations that did not reach consensus within the working group (n=16) were externally evaluated by expert nurses in intravesical antineoplastic therapy from various oncological contexts identified by intentional and snowball sampling (N=19 Round I, N=16 Round II). Four initial recommendations did not reach consensus; two were eliminated, and the remaining were evaluated in a second round.
This study successfully adapted the recommendations to the Portuguese context, promoting evidence-based practices. Validation by an expert panel confirms their relevance and applicability, strengthening oncological care in Portugal.
Downloads
References
1. Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer Journal for Clinicians. 2024;74(3):229-63.
2. Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, et al. Global cancer observatory: cancer today (version 1.1). Lyon, France: International Agency for Research on Cancer. 2024.
3. Liu G, Li B, Xu Z, Wang J, Ma S, Kan Y, et al. Bacillus calmette-guerin for the treatment of non-muscle invasive bladder cancer: history and current status. Discovery Medicine. 2022;33(169):85-92.
4. Witjes JA, Bruins HM, Cathomas R, Compérat EM, Cowan NC, Gakis G, et al. European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. European Urology. 2021;79(1):82-104.
5. Lobo N, Brooks NA, Zlotta AR, Cirillo JD, Boorjian S, Black PC, et al. 100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19. Nature Reviews Urology. 2021;18(10):611-22.
6. Duan H, Deng Z, Zou J, Zhang G, Zou X, Xie T. The Efficacy and Safety of Hyperthermia Intravesical Chemotherapy in the Treatment of Non-Muscle-Invasive Bladder Cancer: A Meta-Analysis. Urologia Internationalis. 2024;108(4):322-33.
7. Li R, Li Y, Song J, Gao K, Chen K, Yang X, et al. Intravesical gemcitabine versus mitomycin for non-muscle invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trial. BMC Urology. 2020;20:1-8.
8. Burroughs GE, Connor TH, Mead KR, Reed LD. Preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings. CA Cancer Journal for Clinicians. 2006;56(6):354-65.
9. Lauridsen SV, De Blok W, Retinger NL, Jensen BT, Turner B, Villa G, et al. Intravesical instillation with mitomycin C or bacillus Calmette-Guérin in non-muscle invasive bladder cancer: European Association of Urology Nursing; 2015.
10. Keeney S, Hasson F, McKenna H. Consulting the oracle: ten lessons from using the Delphi technique in nursing research. Journal of Advanced Nursing. 2006;53(2):205-12.
11. Benner P. From novice to expert: Excellence and power in clinical nursing practice. Commemorative edition: Prentice-Hall International London; 2001.
12. Portuguese Nursing Order Parecer n.º 10/2017: Diferenciação das intervenções de enfermagem do enfermeiro especialista em enfermagem médico-cirúrgica em relação ao enfermeiro generalista, num serviço de urgência. 2017.
13. Kennedy HP. Enhancing Delphi research: methods and results. Journal of Advanced Nursing. 2004;45(5):504-11.
14. Gisev N, Bell JS, Chen TF. Interrater agreement and interrater reliability: key concepts, approaches, and applications. Research in Social and Administrative Pharmacy. 2013;9(3):330-8.
15. Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. Journal of Chiropractic Medicine. 2016;15(2):155-63.
16. European Commission. Guidance for the Safe Management of Hazardous Medicinal Products at Work. 2023.
17. Peyton CC, Chipollini J, Azizi M, Kamat AM, Gilbert SM, Spiess PE. Updates on the use of intravesical therapies for non-muscle invasive bladder cancer: how, when and what. World Journal of Urology. 2019;37:2017-29.
18. Szewczyk Jr MT, Soefje SA. Development of an innovative delivery system for bacillus Calmette-Guérin bladder administration. American Journal of Health-System Pharmacy. 2021;78(1):60-4.
19. Marx AH, Nowicki DN, Carlson RB, Schultz KM, Sickbert-Bennett E, Weber DJ. Bacille Calmette-Guérin preparation and intravesical administration to patients with bladder cancer: risks to healthcare personnel and patients, and mitigation strategies. Infection Control & Hospital Epidemiology. 2024;45(4):520-5.
20. Liu S, Zhang C, Peng L, Lu Y, Luo D. Comparative effectiveness and safety of intravesical instillation treatment of interstitial cystitis/bladder pain syndrome: a systematic review and network meta-analysis of randomized controlled trials. International Urogynecology Journal. 2021;32:1061-71.
21. Simons A, Toland S. Protecting nurses against the risks of occupational exposure to systemic anticancer therapy agents. Cancer Nursing Practice. 2024;23(4).
22. Connor TH, McDiarmid MA. Preventing occupational exposures to antineoplastic drugs in health care settings. CA Cancer Journal for Clinicians. 2006;56(6):354-65.
23. Wang T, Tan J-YB, Liu X-L, Zhao I. Barriers and enablers to implementing clinical practice guidelines in primary care: an overview of systematic reviews. BMJ open. 2023;13(1):e062158.
24. Wang Z, Norris SL, Bero L. The advantages and limitations of guideline adaptation frameworks. Implementation Science. 2018;13:1-13.
25. Klaic M, Kapp S, Hudson P, Chapman W, Denehy L, Story D, et al. Implementability of healthcare interventions: an overview of reviews and development of a conceptual framework. Implementation Science. 2022;17(1):10.
26. Bora A-M, Piechotta V, Kreuzberger N, Monsef I, Wender A, Follmann M, et al. The effectiveness of clinical guideline implementation strategies in oncology—a systematic review. BMC Health Services Research. 2023;23(1):347.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Filipa Ventura, Vânia Maria Azevedo Ribeiro, Inês Gonçalves Vicente Claro, Armando Luís Teixeira dos Santos Silva, Ana Rita Águas Afonso Silva, Susana Cláudia Fernandes Gonçalves Marques, Maria Cecília Magalhães Girão, Cristina Maria Oliveira Santos, Raquel Chemela, Maria Esmeralda Reis Barreira
This work is licensed under a Creative Commons Attribution 4.0 International License.
